Terms: = Skin cancer AND TET1, KIAA1676, 80312, ENSG00000138336, CXXC6, bA119F7_1, Q8NFU7, LCX AND Treatment
22788 results:
1. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
Syc-Mazurek SB; Zhao-Fleming H; Guo Y; Tisavipat N; Chen JJ; Zekeridou A; Kournoutas I; Orme JJ; Block MS; Lucchinetti CF; Mustafa R; Flanagan EP
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200249. PubMed ID: 38696737
[TBL] [Abstract] [Full Text] [Related]
2. Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Sarin KY; Bradshaw M; O'Mara C; Shahryari J; Kincaid J; Kempers S; Tu JH; Dhawan S; DuBois J; Wilson D; Horwath P; de Souza MP; Powala C; Kochendoerfer GG; Plotkin SR; Webster GF; Le LQ
Sci Adv; 2024 May; 10(18):eadk4946. PubMed ID: 38691597
[TBL] [Abstract] [Full Text] [Related]
3. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
4. Hepatic artery infusion chemotherapy with systemic capecitabine and camrelizumab for treating unresectable hilar cholangiocarcinoma: An initial investigation of efficacy and safety.
Li L; Liu S; Wang Q; Wang Y; Yu G
J Cancer Res Ther; 2024 Apr; 20(2):578-583. PubMed ID: 38687927
[TBL] [Abstract] [Full Text] [Related]
5. Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment.
Meher RK; Mir SA; Singh K; Mukerjee N; Nayak B; Kumer A; Zughaibi TA; Khan MS; Tabrez S
J Cell Mol Med; 2024 May; 28(9):e18263. PubMed ID: 38685671
[TBL] [Abstract] [Full Text] [Related]
6. Management of post-Mohs surgical wounds with a hypothermically stored amniotic membrane: a case series.
Kapp D; Pfendler L
J Wound Care; 2024 May; 33(Sup5):S22-S27. PubMed ID: 38683816
[TBL] [Abstract] [Full Text] [Related]
7. The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases.
Xie J; Chen X; Zheng M; Zhu J; Mao H
Front Biosci (Landmark Ed); 2024 Apr; 29(4):143. PubMed ID: 38682186
[TBL] [Abstract] [Full Text] [Related]
8. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
[TBL] [Abstract] [Full Text] [Related]
9. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract] [Full Text] [Related]
10. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
11. Complications and Recurrences after Excision and Reconstruction of Eyelid Tumours.
Balchev G
Curr Oncol; 2024 Mar; 31(4):1713-1724. PubMed ID: 38668033
[TBL] [Abstract] [Full Text] [Related]
12. Near-infrared hyperspectral imaging and robust statistics for in vivo non-melanoma skin cancer and actinic keratosis characterisation.
Courtenay LA; Barbero-García I; Martínez-Lastras S; Del Pozo S; Corral de la Calle M; Garrido A; Guerrero-Sevilla D; Hernandez-Lopez D; González-Aguilera D
PLoS One; 2024; 19(4):e0300400. PubMed ID: 38662718
[TBL] [Abstract] [Full Text] [Related]
13. [Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor].
Lei JY; Li Y; Li CM; Xiong XL; Feng CC; Weng WJ; Peng XM; Zhou DH; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):445-449. PubMed ID: 38660850
[TBL] [Abstract] [Full Text] [Related]
14. Photobiomodulation in the treatment of palmar-plantar erythrodysesthesia: a randomised controlled clinical study protocol.
Lestido V; Rodríguez F; Rodríguez A; Pombo V; Barrios R; Pavani C
BMJ Open; 2024 Apr; 14(4):e081459. PubMed ID: 38657999
[TBL] [Abstract] [Full Text] [Related]
15. skin Changes in Suspected Lyme Disease.
Vržogić P; Perica A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
[TBL] [Abstract] [Full Text] [Related]
16. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract] [Full Text] [Related]
17. Multifocal Infantile Hemangioma - Presentation of 4 Cases and Review of the Selected Literature.
Matić A; Matić M; Prćić S; Radulović A; Pajić M; Žeravica M
Acta Dermatovenerol Croat; 2023 Dec; 31(4):208-212. PubMed ID: 38651847
[TBL] [Abstract] [Full Text] [Related]
18. Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis.
Kaemmerer T; Guertler A; Clanner-Engelshofen BM; Fuchs C; French LE; Reinholz M
Acta Dermatovenerol Croat; 2023 Dec; 31(4):184-190. PubMed ID: 38651844
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
[TBL] [Abstract] [Full Text] [Related]
20. First-line treatment Patterns and Outcomes in Advanced Non-Small Cell Lung cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy.
Wagenius G; Vikström A; Berglund A; Salomonsson S; Bencina G; Hu X; Chirovsky D; Brunnström H
Acta Oncol; 2024 Apr; 63():198-205. PubMed ID: 38643377
[TBL] [Abstract] [Full Text] [Related]
[Next]